Nicolas PANAYOTIS;MICHAEL FAINZILBER;Yeda Research and Development Co. Ltd.
发明人:
MICHAEL FAINZILBER,Nicolas PANAYOTIS
申请号：
IL25215117
公开号：
IL252151D0
申请日:
2017.05.07
申请国别(地区):
IL
年份:
2017
代理人:
摘要：
Agents and methods of treating a psychiatric stress disorder, Rett syndrome, MeCP2 duplication syndrome or multiple sclerosis are provided. Accordingly there is provided an agent capable of down-regulating activity and/or expression of importin alpha5 for use in the treatment of a medical condition selected from the group consisting of psychiatric stress disorder, Rett syndrome, MeCP2 duplication syndrome and multiple sclerosis. Also provided are methods of identifying an agent that inhibits activity of importin alpha5.
